MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - IMPLICATIONS FOR RENAL SURVIVAL

被引:21
作者
ABBOTT, KC
SANDERS, LR
BAKRIS, GJ
机构
[1] RUSH MED COLL,RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT PREVENT MED,CHICAGO,IL 60612
[2] RUSH MED COLL,DEPT INTERNAL MED,CHICAGO,IL 60612
[3] RUSH MED COLL,DIV NEPHROL,CHICAGO,IL 60612
[4] RUSH MED COLL,DIV ENDOCRINOL,CHICAGO,IL 60612
[5] BROOKE ARMY MED CTR,DEPT MED,DIV NEPHROL,FT SAM HOUSTON,TX 78234
[6] UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV NEPHROL,SAN ANTONIO,TX 78284
关键词
D O I
10.1001/archinte.154.2.146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microvascular and macrovascular disease cause considerable mortality and morbidity both among patients with non-insulin-dependent diabetes mellitus and those with insulin-dependent diabetes mellitus. Furthermore, non-insulin-dependent and insulin-dependent diabetes mellitus overlap in their pathogenesis as well as short- and long-term complications. In the diabetic patient, genetic susceptibility as well as other factors, ie, microalbuminuria, hypertension, high protein intake, blood glucose control, etc, ultimately culminate in a diffuse disease process, eg, diabetic vascular and/or renal disease. Early predictors of susceptibility for development of renal disease in diabetic subjects would help focus our treatment strategies. The role of microalbuminuria as a prognostic marker for the major complications of insulin-dependent diabetes mellitus has been previously reviewed. We reviewed the role of microalbuminuria as a prognostic marker for progression of diabetic renal disease in subjects with non-insulin-dependent diabetes mellitus. We examined treatment strategies to lower microalbuminuria and its associated impact on disease progression.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 109 条
[1]  
AIZAWA T, 1990, CLIN NEPHROL, V33, P130
[2]   CLINICAL-IDENTIFICATION OF NONDIABETIC RENAL-DISEASE IN DIABETIC-PATIENTS WITH TYPE-I AND TYPE-II DISEASE PRESENTING WITH RENAL DYSFUNCTION [J].
AMOAH, E ;
GLICKMAN, JL ;
MALCHOFF, CD ;
STURGILL, BC ;
KAISER, DL ;
BOLTON, WK .
AMERICAN JOURNAL OF NEPHROLOGY, 1988, 8 (03) :204-211
[3]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[4]  
BABA T, 1989, DIABETOLOGIA, V32, P40
[5]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND PROGRESSION OF DIABETIC NEPHROPATHY [J].
BAKRIS, GL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :643-644
[6]  
BAKRIS GL, 1992, CALCIUM ANTAGONISTS, V18, P367
[7]  
BAKRIS GL, 1991, J AM SOC NEPHROL S1, V2, P21
[8]   SODIUM RESTRICTION CORRECTS HYPERFILTRATION OF DIABETES [J].
BANK, N ;
LAHORRA, MAG ;
AYNEDJIAN, HS ;
WILKES, BM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :F668-F676
[9]   SORBINIL PREVENTS GLOMERULAR HYPERPERFUSION IN DIABETIC RATS [J].
BANK, N ;
MOWER, P ;
AYNEDJIAN, HS ;
WILKES, BM ;
SILVERMAN, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (06) :F1000-F1006